Analysis of the anti-Candida activity of tricyclic antidepressants in association with amphotericin B and their antifungal mechanisms-Reference-Cited by-同舟云学术

Analysis of the anti-Candida activity of tricyclic antidepressants in association with amphotericin B and their antifungal mechanisms

Published:2024-08-29 Issue: Volume: Page:
ISSN:1517-8382
Container-title:Brazilian Journal of Microbiology
language:en
Short-container-title:Braz J Microbiol

Author:

de Farias Cabral Vitória Pessoa,Rodrigues Daniel Sampaio,do Amaral Valente Sá Lívia Gurgel,Moreira Lara Elloyse Almeida,da Silva Cecília Rocha,de Andrade Neto João Batista,da Costa Érica Rayanne Mota,Ferreira Thais Lima,de Oliveira Leilson Carvalho,de Souza Beatriz Oliveira,Cavalcanti Bruno Coêlho,Magalhães Islay Lima,de Moraes Manoel Odorico,Júnior Hélio Vitoriano Nobre^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s42770-024-01459-y.pdf

Reference48 articles.

1. Mahalingam SS, Jayaraman S, Pandiyan P (2022) Fungal colonization and infections—interactions with other Human diseases. Pathogens 11:1–16. https://doi.org/10.3390/pathogens11020212

2. WHO (2022) WHO fungal priority pathogens list to guide research, development and public health action

3. Arendrup MC, Arikan-Akdagli S, Jørgensen KM, Barac A, Steinmann J, Toscano C, Arsenijevic VA, Sartor A, Lass-Flörl C, Hamprecht A, Matos T, Rogers BRS, Quiles I, Buil J, Özenci V, Krause R, Bassetti M, Loughlin L, Denis B, Grancini A, White PL, Lagrou K, Willinger B, Rautemaa-Richardson R, Hamal P, Ener B, Unalan-Altintop T, Evren E, Hilmioglu-Polat S, Oz Y, Ozyurt OK, Aydin F, Růžička F, Meijer EFJ, Gangneux JP, Lockhart DEA, Khanna N, Logan C, Scharmann U, Desoubeaux G, Roilides E, Talento AF, van Dijk K, Koehler P, Salmanton-García J, Cornely OA, Hoenigl M (2023) European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study. J Infect 87:428–437. https://doi.org/10.1016/j.jinf.2023.08.001

4. Benedict K, Forsberg K, Gold JAW, Baggs J, Lyman M (2023) Candida Auris–Associated hospitalizations, United States, 2017–2022. Emerg Infect Dis 29:2022–2024. https://doi.org/10.3201/eid2907.230540

5. Zhang Q, Liu F, Zeng M, Mao Y, Song Z (2021) Drug repurposing strategies in the development of potential antifungal agents. Appl Microbiol Biotechnol 105:5259–5279. https://doi.org/10.1007/s00253-021-11407-7